Table 2.
Maternal and neonatal outcomes for HBsAg status
| HBsAg positive (N = 3039) | HBsAg negative (N = 36,500) | P value | |
|---|---|---|---|
| Maternal outcomes [N (%)] | |||
| Gestational hypertension | 18 (0.6%) | 242 (0.7%) | 0.64 |
| Pre-eclampsia | 103 (3.4%) | 924 (2.5%) | < 0.05 |
| GDM | 366 (12.0%) | 3529 (9.7%) | < 0.05 |
| ICP | 32 (1.1%) | 90 (0.2%) | < 0.05 |
| PROM | 213 (7.0%) | 2763 (7.6%) | 0.26 |
| Oligohydramnios | 265 (8.7%) | 3378 (9.3%) | 0.32 |
| Polyhydramnios | 14 (0.5%) | 158 (0.4%) | 0.82 |
| PPH | 152 (5.0%) | 2159 (5.9%) | 0.05 |
| Neonatal outcomes [N (%)] | |||
| Preterm birth | 119 (3.9%) | 1720 (4.4%) | 0.22 |
| Fetal distress | 149 (4.9%) | 1728 (4.7%) | 0.67 |
| Asphyxia neonatorum | 52 (1.7%) | 496 (1.4%) | 0.11 |
| Overweight offspring | 4 (0.1%) | 1029 (2.8%) | 0.57 |
| FGR | 64 (2.1%) | 790 (2.2%) | 0.83 |
| Transfer to the NICU | 434 (14.3%) | 4417 (12.1%) | 0.35 |